Search - tctmd.com

Displaying 981 - 1000 of 1190

Sort: Relevancy | Date

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

News Daily News

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

L.A. McKeown

May 23, 2018

News Conference News HRS 2018

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

Todd Neale

May 18, 2018

News Daily News

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Caitlin E. Cox

May 16, 2018

News Featured Fellow

Shivanshu Madan, MD

Yael L. Maxwell

May 14, 2018

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Conference News EAS 2018

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Yael L. Maxwell

May 07, 2018

News Daily News

Alirocumab Price Slashed in Deal With Express Scripts

Michael O'Riordan

May 03, 2018

News Conference News SCAI 2018

Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI

Todd Neale

April 27, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

News Daily News

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

Michael O'Riordan

April 20, 2018

News Daily News

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

Michael O'Riordan

April 16, 2018

News Daily News

Abciximab in ‘Short Supply’ Worldwide

Shelley Wood

April 13, 2018

News Daily News

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Shelley Wood

April 06, 2018

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

News Daily News

One in Three Cardiac Patients Use Complementary Health, Often Unbeknownst to Their Doctors

Yael L. Maxwell

April 05, 2018

News Daily News

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Yael L. Maxwell

April 04, 2018

Advertisement

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Shivanshu Madan, MD

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Alirocumab Price Slashed in Deal With Express Scripts

Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

Abciximab in ‘Short Supply’ Worldwide

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

One in Three Cardiac Patients Use Complementary Health, Often Unbeknownst to Their Doctors

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content